BLND compared with MXCT: revenue, margins and what each company keeps, and the suppliers and customers both name

BLNDBlend Labs, Inc.

Mkt capRevenueRevenue

MXCTMaxcyte, Inc.

Mkt capRevenueRevenue

Compare

BLNDBlend Labs, Inc.

MXCTMaxcyte, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BLND

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▼−13.71%—

Q2 FY26±49.5%▼−16.41%×0.33

May 8 '26±16.5%▼−14.81%×0.90

Q1 FY26±26.5%▲+11.66%×0.44

MXCT

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±81.8%▲+9.45%×0.11

May 13 '26±90.0%▲+24.06%×0.27

= impliedBLND realized, solidMXCT realized, hatchedOne scale, both sides: full bar = 90%× = |realized| ÷ impliedSource: market data

Q1 FY26

—

▼−6.81%

—

Jan 13 '26±65.8%▼−3.68%×0.06

BLNDBlend Labs, Inc.

0.97▼−15.11%· post 0.97

Mkt cap$234.4MRevenue$33MQ3 FY26Revenue$124MFY25

MXCTMaxcyte, Inc.

1.25▼−4.21%· post 1.28

ClosedNov 6 '26

Mkt cap$130.0MRevenue$7MQ2 FY26Revenue$33MFY25

Compare

ClosedNov 6 '26

BLNDBlend Labs, Inc.

MXCTMaxcyte, Inc.

0.97▼−15.11%post 0.97

Price

1.25▼−4.21%post 1.28

$234.4M

Mkt cap

$130.0M

Q3 FY26$33M

Revenue

$7MQ2 FY26

FY25$124M

Revenue

$33MFY25

BLND0.97▼−15.11%vsMXCT1.25▼−4.21%ClosedNov 6 '26